These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37620089)

  • 1. Botulinum toxin for motor disorders.
    Safarpour D; Jabbari B
    Handb Clin Neurol; 2023; 196():539-555. PubMed ID: 37620089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum Toxin Treatment of Motor Disorders in Parkinson Disease-A Systematic Review.
    Jabbari B; Comtesse SM
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System.
    Yoshida K
    Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of movement disorders using botulinum toxin].
    Burgunder JM
    Schweiz Med Wochenschr; 1992 Sep; 122(36):1311-6. PubMed ID: 1411387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal limb dystonia and tremor: Clinical update.
    Murgai AA; Jog M
    Toxicon; 2020 Mar; 176():10-14. PubMed ID: 31965968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Simpson DM; Blitzer A; Brashear A; Comella C; Dubinsky R; Hallett M; Jankovic J; Karp B; Ludlow CL; Miyasaki JM; Naumann M; So Y;
    Neurology; 2008 May; 70(19):1699-706. PubMed ID: 18458230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on the neurologic applications of botulinum toxins.
    Evidente VG; Adler CH
    Curr Neurol Neurosci Rep; 2010 Sep; 10(5):338-44. PubMed ID: 20567945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum neurotoxin: the ugly duckling.
    Koussoulakos S
    Eur Neurol; 2009; 61(6):331-42. PubMed ID: 19365125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local treatment of dystonia and spasticity with injections of botulinum-A toxin.
    Calne S
    Axone; 1993 Jun; 14(4):85-8. PubMed ID: 8274387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin: State of the art.
    Jankovic J
    Mov Disord; 2017 Aug; 32(8):1131-1138. PubMed ID: 28639368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.
    Hallett M; Albanese A; Dressler D; Segal KR; Simpson DM; Truong D; Jankovic J
    Toxicon; 2013 Jun; 67():94-114. PubMed ID: 23380701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Movement, visceral and autonomic disorders: use of botulinum toxin.
    Moore AP
    Hosp Med; 2003 Aug; 64(8):452-9. PubMed ID: 12958755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Botulinum Toxin for Treatment of the Dystonias.
    Berardelli A; Conte A
    Handb Exp Pharmacol; 2021; 263():107-126. PubMed ID: 31820178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.
    Pullman SL; Greene P; Fahn S; Pedersen SF
    Arch Neurol; 1996 Jul; 53(7):617-24. PubMed ID: 8929169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxins: pharmacology and its current therapeutic evidence for use.
    Panicker JN; Muthane UB
    Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Botulinum toxin therapy: from dreaded biological toxin to standard pharmaceutical].
    Schnider P; Voller B; Moraru K; Auff E
    Wien Klin Wochenschr; 1999 Oct; 111(20):825-9. PubMed ID: 10586486
    [No Abstract]   [Full Text] [Related]  

  • 18. Botulinum toxin for the treatment of movement disorders.
    Thenganatt MA; Fahn S
    Curr Neurol Neurosci Rep; 2012 Aug; 12(4):399-409. PubMed ID: 22661378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dystonia: medical therapy and botulinum toxin.
    Jankovic J
    Adv Neurol; 2004; 94():275-86. PubMed ID: 14509685
    [No Abstract]   [Full Text] [Related]  

  • 20. Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
    Tilton AH
    J Child Neurol; 2003 Sep; 18 Suppl 1():S50-66. PubMed ID: 13677571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.